Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation

The Washington University logo

The Washington University

Status

Withdrawn

Conditions

Sedation

Treatments

Drug: dexmedetomidine sedation protocol
Drug: pentobarbital sedation protocol

Study type

Interventional

Funder types

Other

Identifiers

NCT00878345
colegroenersterni

Details and patient eligibility

About

The investigators believe dexmedetomidine will provide superior sedation with reduced side effects and reduced time to discharge compared with pentobarbital. The investigators have developed sedation protocols with pentobarbital and dexmedetomidine in our ambulatory procedure center. These protocols are both routinely used for sedation in our unit. The investigators propose to study these two protocols in children ages 6 months to 6 years presenting to the ambulatory procedure center for non-painful procedural sedation. The investigators will compare failure of sedation, side effect profile, recovery and discharge times between the two pharmacologic protocols.

Sex

All

Ages

6 months to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Requiring sedation for non-painful procedures
  • Normal airway per exam

Exclusion criteria

  • Congenital syndromes with known difficult airways
  • Known difficult airway during past anesthesia or sedation experience
  • Parent/guardian refusal of participation

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 2 patient groups

1
Active Comparator group
Description:
Dexmedetomidine sedation protocol
Treatment:
Drug: dexmedetomidine sedation protocol
2
Active Comparator group
Description:
Pentobarbital sedation protocol
Treatment:
Drug: pentobarbital sedation protocol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems